Search

Eric Olson

Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1693, 1673, 1623
Total Applications
1758
Issued Applications
971
Pending Applications
175
Abandoned Applications
632

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7316924 [patent_doc_number] => 20040224058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Maltitol solutions with high maltitol content and methods of making same' [patent_app_type] => new [patent_app_number] => 10/804502 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4978 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224058.pdf [firstpage_image] =>[orig_patent_app_number] => 10804502 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/804502
Maltitol solutions with high maltitol content and methods of making same Mar 18, 2004 Abandoned
Array ( [id] => 5142695 [patent_doc_number] => 20070004911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Silylated oligonucleotide compounds' [patent_app_type] => utility [patent_app_number] => 10/550217 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6426 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004911.pdf [firstpage_image] =>[orig_patent_app_number] => 10550217 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550217
Silylated oligonucleotide compounds Mar 18, 2004 Abandoned
Array ( [id] => 42800 [patent_doc_number] => 07781408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'Formulations for mediating inflammation and for reducing blood cholesterol' [patent_app_type] => utility [patent_app_number] => 10/551789 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 23378 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/781/07781408.pdf [firstpage_image] =>[orig_patent_app_number] => 10551789 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551789
Formulations for mediating inflammation and for reducing blood cholesterol Mar 11, 2004 Issued
Array ( [id] => 7672927 [patent_doc_number] => 20040180852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus' [patent_app_type] => new [patent_app_number] => 10/796707 [patent_app_country] => US [patent_app_date] => 2004-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13812 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180852.pdf [firstpage_image] =>[orig_patent_app_number] => 10796707 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/796707
Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus Mar 8, 2004 Abandoned
Array ( [id] => 7319345 [patent_doc_number] => 20040225015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient' [patent_app_type] => new [patent_app_number] => 10/793857 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11831 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20040225015.pdf [firstpage_image] =>[orig_patent_app_number] => 10793857 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/793857
Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient Mar 7, 2004 Issued
Array ( [id] => 7977651 [patent_doc_number] => 08071572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Preventive/remedy for obesity' [patent_app_type] => utility [patent_app_number] => 10/547776 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3871 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071572.pdf [firstpage_image] =>[orig_patent_app_number] => 10547776 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/547776
Preventive/remedy for obesity Mar 7, 2004 Issued
Array ( [id] => 7447244 [patent_doc_number] => 20040186081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Naaladase inhibitors for treating opioid tolerance' [patent_app_type] => new [patent_app_number] => 10/791296 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22348 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186081.pdf [firstpage_image] =>[orig_patent_app_number] => 10791296 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/791296
Naaladase inhibitors for treating opioid tolerance Mar 2, 2004 Abandoned
Array ( [id] => 7426664 [patent_doc_number] => 20040229824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Methods for using specific saccharides for treating Alzheimer\'s disease and other amyloidoses' [patent_app_type] => new [patent_app_number] => 10/793175 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11197 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229824.pdf [firstpage_image] =>[orig_patent_app_number] => 10793175 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/793175
Methods for using glucose pentasulfate for treating amyloid associated with type II diabetes Mar 2, 2004 Issued
Array ( [id] => 7326832 [patent_doc_number] => 20040253219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability' [patent_app_type] => new [patent_app_number] => 10/786861 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10292 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253219.pdf [firstpage_image] =>[orig_patent_app_number] => 10786861 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/786861
Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability Feb 23, 2004 Issued
Array ( [id] => 7325446 [patent_doc_number] => 20040138239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Compositions and methods for targeting cerebral circulation and treatment of headache' [patent_app_type] => new [patent_app_number] => 10/480162 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6738 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138239.pdf [firstpage_image] =>[orig_patent_app_number] => 10480162 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/480162
Compositions and methods for targeting cerebral circulation and treatment of headache Feb 22, 2004 Abandoned
Array ( [id] => 359840 [patent_doc_number] => 07485719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition, and medical treatment material' [patent_app_type] => utility [patent_app_number] => 10/546256 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18684 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485719.pdf [firstpage_image] =>[orig_patent_app_number] => 10546256 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/546256
Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition, and medical treatment material Feb 19, 2004 Issued
Array ( [id] => 5597081 [patent_doc_number] => 20060160999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Reagents and methods for preparing lps antagonist b1287 and stereoisomers thereof' [patent_app_type] => utility [patent_app_number] => 10/546132 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25664 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160999.pdf [firstpage_image] =>[orig_patent_app_number] => 10546132 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/546132
Reagents and methods for preparing LPS antagonist B1287 and stereoisomers thereof Feb 17, 2004 Issued
Array ( [id] => 7426554 [patent_doc_number] => 20040229817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Inhibitors of Hepatitis C virus, compositions and treatments using the same' [patent_app_type] => new [patent_app_number] => 10/782679 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14406 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229817.pdf [firstpage_image] =>[orig_patent_app_number] => 10782679 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/782679
Inhibitors of Hepatitis C virus, compositions and treatments using the same Feb 17, 2004 Abandoned
Array ( [id] => 7409449 [patent_doc_number] => 20040176273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Regulation of mammalian keratinous tissue using hexamidine compositions' [patent_app_type] => new [patent_app_number] => 10/780267 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18203 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176273.pdf [firstpage_image] =>[orig_patent_app_number] => 10780267 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/780267
Regulation of mammalian keratinous tissue using hexamidine compositions Feb 16, 2004 Abandoned
Array ( [id] => 7353621 [patent_doc_number] => 20040249178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Conjugates and compositions for cellular delivery' [patent_app_type] => new [patent_app_number] => 10/780447 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 53151 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20040249178.pdf [firstpage_image] =>[orig_patent_app_number] => 10780447 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/780447
Conjugates and compositions for cellular delivery Feb 12, 2004 Issued
Array ( [id] => 7139006 [patent_doc_number] => 20050182241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Universal support for nucleic acid synthesis' [patent_app_type] => utility [patent_app_number] => 10/776695 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2122 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182241.pdf [firstpage_image] =>[orig_patent_app_number] => 10776695 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/776695
Universal support for nucleic acid synthesis Feb 11, 2004 Abandoned
Array ( [id] => 7276336 [patent_doc_number] => 20040235787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Compositions comprising sugar beet pectin and carotenoids' [patent_app_type] => new [patent_app_number] => 10/486705 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2517 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235787.pdf [firstpage_image] =>[orig_patent_app_number] => 10486705 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/486705
Compositions comprising sugar beet pectin and carotenoids Feb 11, 2004 Abandoned
Array ( [id] => 7122024 [patent_doc_number] => 20050013853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Anti-proliferative drugs' [patent_app_type] => utility [patent_app_number] => 10/774694 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8580 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20050013853.pdf [firstpage_image] =>[orig_patent_app_number] => 10774694 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/774694
Anti-proliferative drugs Feb 9, 2004 Abandoned
Array ( [id] => 7379036 [patent_doc_number] => 20040220267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Derivatives of pentacyclic nortriterpene quinone methides as compounds useful in the treatment of inflammatory, neurodegenerative, and neoplastic diseases' [patent_app_type] => new [patent_app_number] => 10/773903 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1696 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220267.pdf [firstpage_image] =>[orig_patent_app_number] => 10773903 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/773903
Derivatives of pentacyclic nortriterpene quinone methides as compounds useful in the treatment of inflammatory, neurodegenerative, and neoplastic diseases Feb 5, 2004 Abandoned
Array ( [id] => 5721285 [patent_doc_number] => 20060074061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Formulations of glucocorticoids to treat pathologic ocular angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/545053 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3178 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074061.pdf [firstpage_image] =>[orig_patent_app_number] => 10545053 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/545053
Formulations of glucocorticoids to treat pathologic ocular angiogenesis Feb 4, 2004 Abandoned
Menu